Heterogeneous virulence potential and high antibiotic resistance of Pseudomonas aeruginosa strains isolated from Korean pneumonia patients.
Pseudomonas aeruginosa is an opportunistic human pathogen of clinical importance that causes airway infections in immunocompromised patients. Here, we report the virulence-associated characteristics of strains of P. aeruginosa, isolated from the sputa of 25 Korean pneumonia patients. A high degree of genomic plasticity was observed by random amplified polymorphic DNA genotype analysis, suggesting that the infections were caused by strains with diverse genomic backgrounds. Biofilm formation of each isolate was heterogeneous in terms of their relative motilities. In addition, 48% of isolates were defective in the production of 3-oxo-C(12)-HSL (PAI-1), a quorum sensing signal molecule. In these strains, PAI-1-dependent elastase production was correspondingly decreased, suggesting that a large number of strains were presumed to be quorum sensing deficient. Multidrug resistance (MDR) was seen in 56% of the isolates tested, and 44% of the MDR strains were resistant to five or more antibiotics. Taken together, our results provide additional insights into the virulence traits of P. aeruginosa clinical isolates, which will aid in treating P. aeruginosa infections in pneumonia patients.
Yoon
Mi Young
MY
Department of Microbiology, Yonsei University College of Medicine, Seoul, Republic of Korea.
Lee
Kang-Mu
KM
Jeong
Seok Hoon
SH
Kim
Jungmin
J
Yoon
Sang Sun
SS
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D018441:Biofilms; D002675:Child, Preschool; D024881:Drug Resistance, Bacterial; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D010196:Pancreatic Elastase / Q000235:genetics / Q000378:metabolism; D010802:Phylogeny; D017395:Plasminogen Activator Inhibitor 1 / Q000235:genetics / Q000378:metabolism; D011014:Pneumonia / Q000382:microbiology*; D011552:Pseudomonas Infections / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000145:classification / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity*; D056910:Republic of Korea; D014774:Virulence; D037521:Virulence Factors / Q000235:genetics / Q000378:metabolism
D000900:Anti-Bacterial Agents; D017395:Plasminogen Activator Inhibitor 1; D037521:Virulence Factors; D010196:Pancreatic Elastase
Microbiology (Reading). 1999 Jun;145 ( Pt 6):1349-1357
10411261
J Immunol. 2005 Dec 1;175(11):7512-8
16301659
Antimicrob Agents Chemother. 1995 Feb;39(2):489-95
7726519
FEMS Microbiol Lett. 2009 Dec;301(2):210-7
19878323
Mol Microbiol. 1998 Oct;30(2):295-304
9791175
Antimicrob Agents Chemother. 1997 Sep;41(9):2009-12
9303403
Nature. 2003 Nov 20;426(6964):306-10
14628055
J Infect Chemother. 2009 Jun;15(3):125-42
19554398
J Antimicrob Chemother. 2009 Aug;64(2):294-300
19468029
Infect Immun. 1986 Jan;51(1):115-8
3079727
J Clin Invest. 1999 Sep;104(6):743-50
10491409
Lung. 2000;178(3):181-9
10871436
PLoS Pathog. 2010 Jan 08;6(1):e1000712
20072604
Rev Argent Microbiol. 1985;17(2):89-96
3939694
Infection. 1987 Jan-Feb;15(1):47-50
3106228
J Trauma. 2009 May;66(5):1336-42; discussion 1342
19430236
FEMS Microbiol Lett. 2009 Jan;290(1):1-9
19016870
J Clin Microbiol. 2000 Dec;38(12):4614-5
11101604
Environ Microbiol. 2009 Feb;11(2):279-88
19196266
J Bacteriol. 1997 Sep;179(18):5756-67
9294432
Ann Clin Microbiol Antimicrob. 2006 Jun 08;5:14
16762075
Infect Immun. 1974 Jul;10(1):128-35
4210424
J Clin Invest. 2006 Feb;116(2):436-46
16440061
J Clin Microbiol. 1996 May;34(5):1129-35
8727889
Expert Rev Anti Infect Ther. 2004 Aug;2(4):611-23
15482224
J Antimicrob Chemother. 2009 Aug;64(2):229-38
19520717
J Clin Microbiol. 2005 Oct;43(10):5247-55
16207991
Adv Drug Deliv Rev. 2002 Dec 5;54(11):1425-43
12458153
Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):197-201
8278364
Am Rev Respir Dis. 1982 Dec;126(6):1070-3
6817677
J Clin Microbiol. 1986 Aug;24(2):260-4
3018037
J Clin Microbiol. 2004 Feb;42(2):554-62
14766816
Appl Environ Microbiol. 2005 Aug;71(8):4809-21
16085879
Infect Immun. 1985 Feb;47(2):555-60
3917980
J Cyst Fibros. 2009 Jan;8(1):66-70
18974024
Nature. 2001 Oct 25;413(6858):860-4
11677611
J Clin Microbiol. 2007 Jun;45(6):1697-704
17392437
J Antimicrob Chemother. 2006 Dec;58(6):1250-3
17030516